Skip to main content
Table of Contents
Print

What Are the Key Gaps in Research on Cannabis and Anorexia? 

Author: Dr. Clarissa Morton, PharmD

While interest in cannabis as a therapeutic tool is growing, significant cannabis research gaps in anorexia remain. Current evidence is limited, often based on small studies or anecdotal reports, leaving important questions unanswered. 

For patients and clinicians, identifying these gaps is vital in shaping the direction of future research and treatment strategies. 

Areas Where Research Is Still Lacking 

Several limitations prevent cannabis from being fully understood or integrated into anorexia treatment. 

Future Studies 

More future studies are needed with larger sample sizes, longer follow-ups, and controlled designs to determine cannabis’s true effectiveness and safety in anorexia care. 

Limitations 

Current limitations include variability in dosing, formulations, and patient populations, which makes it difficult to compare results or establish clear recommendations. 

Evidence Needs 

There are clear evidence needs for understanding which cannabinoids are most effective, how they interact with psychological therapies, and their long-term effects on recovery. 

In summary, closing the cannabis research gaps in anorexia will require rigorous trials and stronger data. Only then can cannabis move from an experimental option to a more widely accepted part of treatment. 

Visit providers like LeafEase for updates on emerging studies and future directions in cannabis and anorexia research. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Anorexia.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories